RHO GTPase family in hepatocellular carcinoma

Tiantian Wang1, Dean Rao1, Chengpeng Yu1

  • 1Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Clinical Medicine Research Center for Hepatic Surgery of Hubei Province, Key Laboratory of Organ Transplantation, Ministry of Education and Ministry of Public Health, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.

Insights

RHO GTPases are key regulators of cell functions and are implicated in hepatocellular carcinoma (HCC) progression. This review details their role in HCC metastasis and discusses targeted inhibitors for potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • RHO GTPases, a conserved protein subfamily, regulate critical cellular processes like actin cytoskeleton organization, proliferation, and vesicular transport.
  • Emerging evidence links RHO GTPase activity to cancer development, particularly in hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To provide a comprehensive overview of RHO GTPase classification, structure, regulation, and function.
  • To elucidate the specific roles of RHO GTPases in hepatocellular carcinoma (HCC) proliferation, migration, invasion, and metastasis.
  • To review current inhibitors targeting RHO GTPases and identify future research directions for enhanced therapeutic efficacy.

Main Methods:

  • Literature review and synthesis of existing research on RHO GTPases.
  • Analysis of studies focusing on RHO GTPase involvement in HCC pathogenesis.
  • Compilation and evaluation of data on RHO GTPase inhibitors.

Main Results:

  • RHO GTPases are crucial for cellular functions and play a significant role in HCC tumorigenesis and progression.
  • Specific RHO GTPase pathways are implicated in the migration, invasion, and metastasis of HCC cells.
  • Various inhibitors targeting RHO GTPases have been developed, with ongoing efforts to improve their potency.

Conclusions:

  • RHO GTPases are critical effectors in HCC development and metastasis.
  • Targeting RHO GTPases presents a promising therapeutic avenue for HCC treatment.
  • Further research is needed to optimize RHO GTPase inhibitors for clinical application in HCC.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
8.5K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K